Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgAN - IgA Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07820995
What this trial is testing

Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)Immunoglobulin A Nephropathy (IgAN)
University of Illinois at Chicago 20
Not applicableUnknownNCT01815190
What this trial is testing

IgA-positive Versus IgA-negative Immune Complex Vasculitis

Who this might be right for
Cutaneous Vasculitis
University Hospital Muenster 300
Not applicableLooking for participantsNCT05791162
What this trial is testing

Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Besancon 75
Not applicableLooking for participantsNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Not applicableUnknownNCT01126931
What this trial is testing

Wormwood in Chronic Progressive Disorders With Reduced Appetite

Who this might be right for
Cancer
University Hospital Freiburg 300
Testing effectiveness (Phase 2)Study completedNCT00446251
What this trial is testing

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 14
Large-scale testing (Phase 3)Active Not RecruitingNCT05797610
What this trial is testing

Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Who this might be right for
Primary IgA Nephropathy
Hoffmann-La Roche 459
Not applicableStudy completedNCT00793585
What this trial is testing

A Controlled Study of Uric Acid on the Progression of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 40
Post-approval studies (Phase 4)Study completedNCT04525729
What this trial is testing

Rituximab and RASi in Patients with IgAN

Who this might be right for
IgA Nephropathy
Nan Chen,MD 116
Large-scale testing (Phase 3)WithdrawnNCT00599963
What this trial is testing

Paricalcitol for the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Chinese University of Hong Kong
Not applicableLooking for participantsNCT07822100
What this trial is testing

To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic Strategies

Who this might be right for
IgA Nephropathy (IgAN)Henoch Schönlein Purpura Nephritis
Hong Zhang 374
Large-scale testing (Phase 3)UnknownNCT02662283
What this trial is testing

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

Who this might be right for
IGA Nephropathy
Sun Yat-sen University 75
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06291376
What this trial is testing

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A NephropathyIgAN
Alexion Pharmaceuticals, Inc. 579
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07474636
What this trial is testing

Efficacy and Safety Study of HS-10542 for IgA Nephropathy

Who this might be right for
IgANImmunoglobulin A Nephropathy (IgAN)Glomerular Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT01225445
What this trial is testing

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Who this might be right for
Biopsy-confirmed IgA NephropathyProteinuria Less Than 0.5 g Per DayNormal Blood Pressure+1 more
Chinese University of Hong Kong 60
Not applicableUnknownNCT05132621
What this trial is testing

The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.

Who this might be right for
Systemic Lupus ErythematosusImmunoglobulin A Nephropathy
Medical University of Warsaw 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Not applicableUnknownNCT02829164
What this trial is testing

Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region

Who this might be right for
Tonsillectomy
University Hospital, Strasbourg, France 20
Testing effectiveness (Phase 2)Looking for participantsNCT07522099
What this trial is testing

Chinese Adults With Kidney Disease

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN
ADARx Pharmaceuticals, Inc. 30
Next Page